HRP20020909A2 - Zolpidem hemitartrate - Google Patents

Zolpidem hemitartrate Download PDF

Info

Publication number
HRP20020909A2
HRP20020909A2 HR20020909A HRP20020909A HRP20020909A2 HR P20020909 A2 HRP20020909 A2 HR P20020909A2 HR 20020909 A HR20020909 A HR 20020909A HR P20020909 A HRP20020909 A HR P20020909A HR P20020909 A2 HRP20020909 A2 HR P20020909A2
Authority
HR
Croatia
Prior art keywords
zolpidem hemitartrate
zolpidem
hemitartrate
preparation
particles
Prior art date
Application number
HR20020909A
Other languages
English (en)
Croatian (hr)
Inventor
Judih Aronhime
David Leonov
Erzsebet Meszaros-Sos
Szaboles Salyi
Csaba Szabo
Shlomo Zavurov
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27394001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020909(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HRP20020909A2 publication Critical patent/HRP20020909A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other Liquid Machine Or Engine Such As Wave Power Use (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Amplifiers (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
HR20020909A 2000-04-24 2001-04-24 Zolpidem hemitartrate HRP20020909A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19929800P 2000-04-24 2000-04-24
US20602500P 2000-05-22 2000-05-22
US22536400P 2000-08-14 2000-08-14
PCT/US2001/013175 WO2001080857A1 (en) 2000-04-24 2001-04-24 Zolpidem hemitartrate

Publications (1)

Publication Number Publication Date
HRP20020909A2 true HRP20020909A2 (en) 2004-08-31

Family

ID=27394001

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020909A HRP20020909A2 (en) 2000-04-24 2001-04-24 Zolpidem hemitartrate

Country Status (21)

Country Link
US (8) US20020077332A1 (enExample)
EP (1) EP1292304B1 (enExample)
JP (3) JP2003531173A (enExample)
KR (1) KR20030069796A (enExample)
AT (4) ATE348613T1 (enExample)
AU (2) AU2001257213B2 (enExample)
CA (1) CA2406982A1 (enExample)
CZ (1) CZ20023775A3 (enExample)
DE (7) DE60125429T2 (enExample)
DK (1) DK1292304T3 (enExample)
ES (4) ES2239558T3 (enExample)
HR (1) HRP20020909A2 (enExample)
HU (1) HUP0300701A2 (enExample)
IL (1) IL152411A0 (enExample)
NZ (1) NZ522015A (enExample)
PL (1) PL358548A1 (enExample)
PT (3) PT1475093E (enExample)
SE (1) SE5292304T3 (enExample)
SK (1) SK16372002A3 (enExample)
WO (1) WO2001080857A1 (enExample)
YU (1) YU79402A (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001284322A1 (en) 2000-08-29 2002-03-13 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
ATE423116T1 (de) 2002-12-18 2009-03-15 Mallinckrodt Inc Synthese von heteroaryl acetamiden
WO2004087703A1 (en) * 2003-03-12 2004-10-14 Sun Pharmaceutical Industries Limited Process for the preparation of n,n,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
EP1660496A1 (en) * 2003-07-31 2006-05-31 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
EP1715853A4 (en) * 2004-02-17 2012-07-18 Transcept Pharmaceuticals Inc COMPOSITIONS FOR THE DISTRIBUTION OF HYPNOTICS IN THE FIELD OF MUNICHCHLEIMHÄUTE AND USE METHOD THEREOF
WO2006008636A2 (en) * 2004-07-16 2006-01-26 Ranbaxy Laboratories Limited Processes for the preparation of zolpidem and its hemitartrate
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070123562A1 (en) * 2005-05-25 2007-05-31 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the-night insomnia
ES2336142T3 (es) * 2005-08-19 2010-04-08 Aventis Pharmaceuticals Inc. Combinacion de un agente hipnotico y un compuesto sustituido, con bis arilo y heteroarilo y aplicacion terapeutica del mismo.
MX2008001705A (es) * 2005-08-19 2008-04-07 Aventis Pharma Inc Combinacion de un agente hipnotico y de r(+)-?-(2,3-dimetoxifenil) -1-[2-(4-fluorofenil)etil]-4-piperidimetanol y su aplicacion terapeutica.
US20080293946A1 (en) * 2005-10-03 2008-11-27 Cheng Brian K Process for Preparing Zolpidem Hemitartrate and Tartrate Polymorphs
US20080200680A1 (en) * 2005-10-17 2008-08-21 Cheng Brian K Polymorph Transformation of Zolpidem in Tablet Matrix
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
JP5066175B2 (ja) 2006-03-31 2012-11-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒスタミンｈ４受容体のモジュレーターとしてのベンゾイミダゾール−２−イルピリミジンおよびピラジン
US20080132535A1 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized Zolpidem Pharmaceutical Compositions
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
KR20110022721A (ko) * 2008-06-30 2011-03-07 얀센 파마슈티카 엔.브이. 벤조이미다졸-2-일 피리미딘 유도체의 제조 방법
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
NZ625712A (en) 2009-11-27 2016-02-26 Genzyme Corp An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
EA201591648A1 (ru) * 2013-03-06 2016-02-29 Янссен Фармацевтика Нв Бензимидазол-2-ил-пиримидиновые модуляторы рецептора гистамина h4
CN116283957A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦水合物及其制备方法
CN116283958A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦共晶体及其制备方法
CN117907368A (zh) * 2024-01-27 2024-04-19 鲁南贝特制药有限公司 一种酒石酸唑吡坦药用晶型d中晶型a、e的定量测定方法
CN118750459B (zh) * 2024-07-22 2025-04-01 常州市武进中医医院 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
IT1130924B (it) * 1980-03-06 1986-06-18 Secifarma Spa Procedimento per la preparazione di spironolattone micronizzato
DE3018940A1 (de) * 1980-05-17 1981-11-26 Hoechst Ag, 6000 Frankfurt Verwendung eines vinylchlorid-pfropf-copolymerisates in der plastisolverarbeitung
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2525601A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
US4675323A (en) * 1985-08-06 1987-06-23 Synthelabo Imidazo(1,2-a)quinoline derivatives useful as anxiolytic agents
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
ES2026666T3 (es) * 1987-03-27 1992-05-01 Synthelabo Procedimiento para preparar derivados de imidazopiridinas.
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
IT1276522B1 (it) * 1995-04-07 1997-10-31 Elena Benincasa Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
ES2195510T3 (es) * 1999-03-25 2003-12-01 Synthon Bv Derivados de imidazopiridina y procedimiento para prepararlos.
WO2000058310A1 (en) * 1999-03-25 2000-10-05 Synthon B.V. Zolpidem salts
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Also Published As

Publication number Publication date
WO2001080857A9 (en) 2002-06-27
DE60122944T2 (de) 2007-04-12
EP1292304A1 (en) 2003-03-19
ES2277301T3 (es) 2007-07-01
DE60125429T2 (de) 2007-09-27
US20040214858A1 (en) 2004-10-28
US20040214859A1 (en) 2004-10-28
ATE335481T1 (de) 2006-09-15
DE04010651T1 (de) 2005-09-01
ES2239558T1 (es) 2005-10-01
DE60114617D1 (de) 2005-12-08
IL152411A0 (en) 2003-05-29
WO2001080857A1 (en) 2001-11-01
JP2006249105A (ja) 2006-09-21
DE60125429D1 (de) 2007-02-01
DK1292304T3 (da) 2005-12-19
DE04010435T1 (de) 2005-09-01
YU79402A (sh) 2006-03-03
ES2239558T3 (es) 2007-04-01
EP1292304A4 (en) 2003-07-23
JP2006137778A (ja) 2006-06-01
PL358548A1 (en) 2004-08-09
AU2001257213B2 (en) 2005-09-29
ES2238941T3 (es) 2007-04-01
DE60114617T2 (de) 2006-07-27
PT1473036E (pt) 2006-10-31
AU5721301A (en) 2001-11-07
US20020077332A1 (en) 2002-06-20
ES2238941T1 (es) 2005-09-16
CA2406982A1 (en) 2001-11-01
DE60122216T2 (de) 2007-08-30
PT1475093E (pt) 2006-11-30
SK16372002A3 (sk) 2003-04-01
JP2003531173A (ja) 2003-10-21
PT1541146E (pt) 2007-01-31
US20040220213A1 (en) 2004-11-04
HUP0300701A2 (hu) 2003-07-28
ES2248321T3 (es) 2006-03-16
EP1292304B1 (en) 2005-11-02
DE60122944D1 (de) 2006-10-19
DE20122435U1 (de) 2005-10-06
DE60122216D1 (de) 2006-09-21
US20040220212A1 (en) 2004-11-04
ATE348613T1 (de) 2007-01-15
US20040220211A1 (en) 2004-11-04
ATE308324T1 (de) 2005-11-15
CZ20023775A3 (cs) 2003-10-15
US20040220210A1 (en) 2004-11-04
ATE338550T1 (de) 2006-09-15
KR20030069796A (ko) 2003-08-27
US20070037843A1 (en) 2007-02-15
SE5292304T3 (enExample) 2005-11-02
NZ522015A (en) 2004-08-27

Similar Documents

Publication Publication Date Title
HRP20020909A2 (en) Zolpidem hemitartrate
AU2001257213A1 (en) Zolpidem hemitartrate
RS56464B1 (sr) Oblik iv ivabradin hidrohlorida
JP2007514000A (ja) テガセロッド塩基及びその塩の多形現象形
HRP20040321A2 (en) Crystalline forms of valacyclovir hydrochloride
HRP20040767A2 (en) Desolvating solvates of atorvastatin hemi-calcium
HRP20100281A2 (hr) Kristalni oblici palonosetron hidroklorida
EP2601175A1 (en) A novel crystalline compound comprising saxagliptin and phosphoric acid
SK8312002A3 (en) Novel forms of pravastatin sodium
MXPA03003761A (es) Formas de cristales y solvatos de clorhidrato de ondansetron y procesos para su preparacion.
EP1473036B1 (en) Zolpidem hemitartrate solvate
ZA200208454B (en) Zolpidem hemitartrate.
US7655800B2 (en) Crystalline 1H-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1H-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
CN116239569B (zh) 一种半琥珀酸拉司米地坦晶型及其制备方法

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20060405

Year of fee payment: 6

OBST Application withdrawn